Topeka, KS: Members of a special legislative committee are supporting recommendations to provide limited medical cannabis access to qualifying patients.
Members of the Special Committee on Federal and State Affairs have called for the approval of legislation in 2020 permitting patients access to non-herbal forms of cannabis, such as edible and topical products. They also recommended providing out-of-state patients with legal protections if they travel to Kansas with medical cannabis.
NORML opposes prohibitions on herbal cannabis formulations and/or inhaling the product.
Legislation enacted earlier this year permits patients with a “debilitating medical condition” to possess oils containing extracts of cannabidiol and only trace percentages of THC. The law provides no regulated system for the production or distribution of high-CBD oil products.
Despite the Committee’s recommendations, representatives from state law enforcement organizations indicate that they will continue to oppose any further medical cannabis access efforts.
For more information, contact Carly Wolf, NORML State Policies Coordinator, at (202) 483-5500.